Cancer results from somatic alterations in key genes, including point mutations, copy-number alterations and structural rearrangements. A powerful way to discover cancer-causing genes is to identify genomic regions that show recurrent copy-number alterations (gains and losses) in tumor genomes. Recent advances in sequencing technologies suggest that massively parallel sequencing may provide a feasible alternative to DNA microarrays for detecting copy-number alterations. Here we present: (i) a statistical analysis of the power to detect copynumber alterations of a given size; (ii) SegSeq, an algorithm to segment equal copy numbers from massively parallel sequence data; and (iii) analysis of experimental data from three matched pairs of tumor and normal cell lines. We show that a collection of B14 million aligned sequence reads from human cell lines has comparable power to detect events as the current generation of DNA microarrays and has over twofold better precision for localizing breakpoints (typically, to within B1 kilobase).
Cancer results from somatic alterations in key genes, including point mutations, copy-number alterations and structural rearrangements. A powerful way to discover cancer-causing genes is to identify genomic regions that show recurrent copy-number alterations (gains and losses) in tumor genomes. Recent advances in sequencing technologies suggest that massively parallel sequencing may provide a feasible alternative to DNA microarrays for detecting copy-number alterations. Here we present: (i) a statistical analysis of the power to detect copynumber alterations of a given size; (ii) SegSeq, an algorithm to segment equal copy numbers from massively parallel sequence data; and (iii) analysis of experimental data from three matched pairs of tumor and normal cell lines. We show that a collection of B14 million aligned sequence reads from human cell lines has comparable power to detect events as the current generation of DNA microarrays and has over twofold better precision for localizing breakpoints (typically, to within B1 kilobase).
Copy-number alterations are a substantial category of genetic variation. Germline copy-number variants can be used for phenotypic mapping in genome-wide association studies and have been linked to various diseases [1] [2] [3] . During carcinogenesis, tumor genomes often acquire somatic chromosomal alterations that can alter the dosage or structure of oncogenes and tumor suppressor genes. A powerful way to find cancer genes is to identify genomic regions with recurrent copy-number alterations (gains and losses) in tumor genomes 4 . Ideally, such characterization should include both the precise identification of the chromosomal breakpoints of each alteration and the accurate estimation of copy numbers in each chromosomal segment. Indeed, hybridization of genomic DNA to oligonucleotide microarrays can reveal genome-wide copy-number changes 5, 6 .
In principle, a simple and powerful approach to assessing copynumber alterations is to perform 'digital karyotyping' . For instance, analyses of whole-genome shotgun sequencing data can delineate germline copy-number variations among individuals [7] [8] [9] . One can use a similar approach to detect copy-number alterations that arise somatically in tumor genomes. In essence, one performs shotgun sequencing of short sequence tags from tumor and normal DNA. The number of sequences aligning to each genomic region should be proportional to its copy number [10] [11] [12] [13] . In practice, however, the high cost of DNA sequencing has greatly limited the practical application of this approach. Recently, a new generation of DNA sequencers has enabled massively parallel sequencing of millions of short sequence reads at dramatically lower costs 8, 14 .
Here we present a detailed analysis of the issues involved in identifying cancer copy-number alterations using massively parallel sequencing. First, we analyzed the statistical power to detect copynumber alterations and to map their boundaries accurately. Second, we developed SegSeq, a computational algorithm to detect these alterations and map their boundaries, taking advantage of the high density of sequence reads. Third, we applied these results to actual sequencing data from Illumina 1G Genome Analyzer, with reads length of 32 or 36 base pairs (bp). With over 10 million aligned sequence reads per sample, we found that copynumber estimates from massively parallel sequencing achieved greater sensitivity, higher dynamic range and greater precision for mapping breakpoints than similar estimates based on microarray hybridization.
For any genomic region, its copy-number ratio equals the number of aligning reads from a tumor sample, divided by the number from the corresponding matched normal sample. One detects a copy-number alteration in regions in which the copynumber ratio deviates from 1. To calculate the power to detect a significant alteration at a fixed genome-wide false-positive rate, we artificially partitioned the genome into nonoverlapping windows of equal size (Fig. 1a) . Then, we used a log-normal approximation for the logarithm of differences in copy-number ratios to calculate the total number of aligning reads required to have 90% power to discriminate between copy number 1, 2 or 3 for regions of various sizes at a stringency of a single false positive in the entire genome. To detect a 50-kb region of a single-copy gain, at this stringency, one requires B15 million aligned reads (Fig. 1b) ; for a single-copy loss one needs B6 million aligned reads (Fig. 1c) .
Algorithm: detecting and localizing copy-number alterations We developed a computational algorithm, called SegSeq, to detect and localize copy-number alterations from massively parallel sequence data. A simple approach would be to partition the genome into windows of fixed size, estimate the tumor-normal ratios for each window and use standard segmentation algorithms to decompose the genome into regions of equivalent copy number 15 . The disadvantage of this approach, however, is that the breakpoints could not be localized more finely than the boundaries of the windows. Instead, we developed an approach with the ability to identify breakpoints at any read position. Our approach is thus not constrained to a window of a prespecified size nor to fixed marker locations (as in microarray hybridization).
Our algorithm is a hybrid of local change-point analysis with a subsequent merging procedure that joins adjacent chromosomal segments ( Fig. 2a-c) . There are three user-defined parameters: w, the number of consecutive reads from the normal sample that defined the local windows for breakpoint initialization; p init , the P-value cutoff for the initial list of candidate breakpoints; and p merge , the P-value cutoff for merging adjacent segments.
In the first step, we hyper-segmented the genome by generating a list of candidate breakpoints based on read counts in local windows. At each tumor read position, we extended a window to the left and to the right to include a fixed number of reads, w, in the normal sample. Then, we calculated the significance (P-value) of a copy-number change based on the log-ratio between the number of tumor reads contained in both windows ( Supplementary Fig. 1 online). Positions which passed a lenient genome-wide significance threshold (P-value o p init ) we declared as candidate breakpoints; these positions demarcated the initial list of segments. In the next step, we iteratively joined segments by eliminating the breakpoint between them, starting from the least significant and continuing as long as its P-value was above p merge . In this step, we calculated Pvalues based on the number of reads in the tumor and normal in the entire segments. As these segments were typically larger than the local windows, the increased number of aligned reads enabled more accurate estimation of statistical significance. b c We optimized the user-defined parameters based on replicate sequencing lanes of a normal sample. The preferred values for these parameters were set as follows: (i) The P-value cutoffs, p init and p merge , controlled the genome-wide false positive rates and were set such that we generated B1,000 false positive initial breakpoints and B10 false positive final segments (Supplementary Methods).
(ii) The local window size, w, was set to maximize the sensitivity to detect alterations, as assessed via spike-in simulations using actual sequence reads obtained from a tumor cell line and its matched normal (Fig. 2d,e) . We tested single-copy alterations varying from 10 kb to 500 kb, assuming B12 million aligned reads in both the tumor and normal samples. At this sequencing depth, we found that w ¼ 400 provided the best sensitivity for single-copy gains at least 50 kb in size (Fig. 2d) and w ¼ 300 provided the best sensitivity for single-copy losses at least 75 kb in size (Fig. 2e) .
Application: copy-number alterations in tumor cell lines To test the methodology, we generated and analyzed massively parallel sequence data on the Illumina 1G Genome Analyzer from three tumor cell lines (HCC1954, HCC1143 and NCI-H2347) and their matched normal cell lines (Supplementary Methods). For each of the six cell lines, we obtained 10-19 million uniquely aligned reads (Supplementary Table 1 online) . The number of observed counts in both normal and tumor cell lines depended on the local G+C content ( Supplementary Figs. 2 and 3 and Supplementary Table 2 online), which may reflect inherent biases in the sample preparation or sequencing procedures. These biases were mitigated by our approach to analyze the ratio of the number of reads seen in tumor DNA and its paired normal DNA, processed at the same time.
We used our segmentation algorithm with these optimized parameters to parse the genome into intervals of constant copy number. After filtering for segments with copy-number ratios greater than 1.5 or less than 0.5, we found 194 copy-number alterations in the HCC1954 cell line, 126 alterations in the HCC1143 cell line and 15 alterations in the NCI-H2347 cell line ( Table 1 , Supplementary Figs. 4-6 and Supplementary Data online). There were six high-level amplifications (copy-number ratios greater than 8), all of which matched previously reported loci 16, 17 . We also found seven regions of homozygous deletion ranging in size from B29 kb to B582 kb (Supplementary Table 3 and Supplementary Fig. 7 online) .
We then compared the results obtained by massively parallel sequencing to the results obtained from hybridization of the same samples to oligonucleotide arrays (Affymetrix SNP Array 6.0). After merging segments that spanned fewer than 8 consecutive probe sets, we found 153 copy-number alterations in the HCC1954 cell line, 93 alterations in the HCC1143 cell line and 18 alterations in the NCI-H2347 cell line.
In general, the copy-number segments detected by both approaches were highly concordant with respect to identifying the existence of a copy-number alteration, whereas massively parallel sequencing had somewhat better resolution for localizing the breakpoints ( Supplementary Fig. 8 online) . Notably, sequencing achieved a higher dynamic range for estimating copy-number alterations. For instance, we considered the high-level amplification of the ERBB2 locus in the HCC1954 cell line. We estimated a 16-fold increase in copy-number ratio by microarrays, compared to a 55.6-fold increase estimated by sequencing ( Supplementary  Figs. 8 and 9 online) . Quantitative PCR measurement confirmed the higher extent of amplification 16 (at B70-fold). This saturation effect of microarray hybridization at high copy numbers could be explained by a Langmuir adsorption model 18 ( Supplementary  Fig. 8 and Supplementary Methods).
Application: mapping breakpoints in tumor cell lines
We next studied our ability to map breakpoints accurately. For this purpose, we considered interstitial homozygous deletions, whose boundaries can be mapped to single-nucleotide resolution by sequencing across the deletion. We detected three homozygous deletions in the NCI-H2347 cell line: a previously unidentified 44-kb deletion at the UTRN locus, as well as previously reported deletions at the PTPRD and HS3ST3A1 loci 19, 20 (Supplementary  Table 3 and Supplementary Figs. 10-12 online) . After confirming that these deletions were absent in the paired normal cell line, we mapped their breakpoints by the conventional sequencing of PCR products spanning each deletion.
Our segmentation algorithm (using B14 million tumor reads) predicted breakpoints that were extremely close to the actual breakpoints (the differences for the six breakpoints being 2, 52, 226, 527, 829 and 1,007 bp, with a mean of 440 bp) (Fig. 3a-c and Supplementary Table 3) . As short sequence reads cannot uniquely align to repeat regions, the presence of Alu repeats flanking three of the six breakpoints limited the precision of mapping. Segmentation of data from microarrays had a mean error of 1,068 bp; it missed the actual breakpoints by +2,718 bp and -1,262 bp for the UTRN locus, by -491 bp and -1,242 bp for the PTPRD locus and by +608 bp and -86 bp for the HS3ST3A1 locus (Fig. 3d-f) .
DISCUSSION
With the advent of powerful new technologies, massively parallel sequencing will provide increasingly high-resolution analyses of copy-number alterations in cancer genomes. We found that a collection of B14 million sequence reads had over two times higher resolution than the current generation of DNA microarrays (median spacing, B700 bp) to localize breakpoints. Our analysis of sequence data from three tumor-normal cell-line pairs provided experimental confirmation of our statistical analyses. Although the sequencing of 14 million reads is currently more expensive than microarray hybridization, relative costs may change with higher sequencing throughput.
Cancer genome analysis will benefit considerably from these improvements in measurement accuracy. A common approach to localizing key cancer-related genes relies on pinpointing a 'common region of overlap' among overlapping gains or losses across hundreds of samples 4, 21, 22 . The increased precision of mapping chromosomal breakpoints in individual samples will identify more precise coordinates for the aggregate overlapping region. Even more importantly, improvements in sequencing will enable the detection of extremely small intragenic events, especially homozygous deletions. For example, we identified four intragenic homozygous deletions ranging in size from 44 kb to 582 kb that affected between one and 15 coding exons. The higher precision of breakpoint mapping may thus help to identify recurrent alterations in tumor suppressor genes that have been previously missed by other genome characterization technologies.
Massively parallel sequencing technologies offer three other key advantages relative to microarray-based hybridization approaches. First, smaller copy-number alterations could be detected by simply increasing the depth of sequencing. Second, one could compensate for stromal admixture in tumor samples by performing deeper sequencing. Third, paired-end sequence reads provide information about structural rearrangements that cannot easily be detected by array-based methods 14 . Future improvements to our method would evaluate the statistical significance for detecting structural rearrangements from paired-end reads.
As sequencing and microarray technologies continue to improve, it will be important to continually benchmark their performance. We anticipate that each massively parallel sequencing platform may be susceptible to particular biases 23, 24 (Supplementary Figs. 2 and 3 online). We propose that the trio of cancer cell lines and the sequence data reported here may provide a useful foundation for such evaluation.
METHODS
Sample preparation, sequencing and alignment. For each cell line, we prepared 3 mg of genomic DNA for sequencing on the Illumina 1G Genome Analyzer 25 (Supplementary Methods).
Statistical analysis of tumor-normal copy-number ratios. We describe a statistical framework for observing a certain number of reads obtained from a tumor and a matched normal sample that align to a genomic window (Supplementary Methods and Supplementary Figs. 1 and 13 online).
Segmentation algorithm for the identification of copy-number alterations. We identified copy-number alterations based on changepoint detection, followed by agglomerative merging of adjacent segments. The input to this algorithm is a list of positions for aligned sequence reads from a tumor sample and a normal sample, and the output includes a list of breakpoints and copynumber estimates for each inferred chromosomal segment (Supplementary Methods).
Comparison of copy-number alterations with single-nucleotide polymorphism arrays. We calculated copy numbers for the Affymetrix Genome-Wide Human SNP Array 6.0 with a GenePattern pipeline 26 according to methods previously described 27 . We optimized parameters for the circular binary segmentation algorithm 28 to infer chromosomal segments of constant copy number from the median of replicate arrays ( Supplementary Fig. 14 online and Supplementary Methods) . We determined consensus chromosomal segments from the list of breakpoints predicted by each method and evaluated the concordance between predicted copy numbers (Supplementary Fig. 8 and Supplementary Methods). with an Affymetrix SNP 6.0 Array, where each point represents the log 2 copy-number ratio interrogated by an array probeset in the UTRN locus (d), the PTPRD locus (e) or the HS3T3A1 locus (f). The minimum value for log 2 copy-number ratios was set to À7. Horizontal blue lines represent copy-number segments inferred by the circular binary segmentation algorithm 28 .
